Insider Surge at FONAR Corp: Hilary Buys 500k+ Shares Post‑Delisting

Corporate News: Insider Buying Surge at FONAR Corp

Insider Activity Following Delisting and Merger

The June 2 2026 filing reveals that Shane Hilary, acting through ODS Capital LLC, purchased 196,336 shares of FONAR Corp. at $19.10 per share. A subsequent transaction of 19,000 shares was executed via the Oliver Shane Irrevocable Trust at $19.12 per share. These acquisitions bring Hilary’s holdings to approximately 520,609 shares, a significant increase from the 324,273 shares reported just one week prior. The timing—immediately after the company’s delisting from Nasdaq and its merger with its parent—suggests a strong confidence in the newly structured entity, even as the public market has ceased to exist.

Implications for Investors and Corporate Governance

For investors who still hold FONAR shares or are considering a position, Hilary’s consistent buying behavior signals a bullish stance from a key insider. Historically, Hilary has added between 71,000 and 225,000 shares in late May, indicating an expectation that the company’s intrinsic value is presently undervalued or that the consolidation provides a strategic opportunity to consolidate control. The delisting removes the liquidity and regulatory transparency that public shareholders rely on; future trading will likely be confined to private transactions or secondary markets. Investors should assess the potential upside of a future secondary offering against the lack of price discovery and limited disclosure.

Insider Profile and Investment Thesis

Shane Hilary’s trading pattern is characterized by large, frequent purchases rather than sporadic sales or speculative activity. Over the past month, he has added more than 500,000 shares in total, consistently buying near market price. This pattern aligns with a long‑term investment thesis that the company’s MRI scanner technology and physician‑practice management services will drive growth. The merger may have provided a catalyst for Hilary to secure a larger stake, positioning him as a key shareholder in the newly formed corporate structure.

Impact on the Healthcare Equipment Sector

FONAR’s transition from a publicly traded entity to a wholly‑owned subsidiary represents a significant shift within the healthcare equipment industry. MRI scanners remain a critical diagnostic tool, and consolidation with its parent could streamline operations and reduce overhead. Hilary’s continued investment indicates that insider confidence may translate into strategic investments in research and development, potentially enhancing the company’s competitive edge. For investors in the broader sector, monitoring how FONAR navigates post‑merger integration—and whether it eventually re‑enters the public markets—will be crucial for assessing long‑term value creation.

Forward‑Looking Considerations

With the transaction occurring after the company’s delisting, the next steps for FONAR likely involve private equity financing, strategic partnerships, or a future IPO. Insider buying is a positive signal, but investors must remain vigilant about the risks associated with private ownership, including limited liquidity and reduced disclosure. As the company continues to evolve, monitoring both insider activity and broader market trends in healthcare equipment will provide insights into its potential for sustainable growth and shareholder returns.